These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2961902)

  • 21. Administration of nonanticoagulant heparin inhibits the loss of glycosaminoglycans from xenogeneic cardiac grafts and prolongs graft survival.
    Stevens RB; Wang YL; Kaji H; Lloveras J; Dalmasso A; Bach FH; Rubinstein P; Sutherland DE; Platt JL
    Transplant Proc; 1993 Feb; 25(1 Pt 1):382. PubMed ID: 8438344
    [No Abstract]   [Full Text] [Related]  

  • 22. Amphiregulin-dependent proliferation of cultured human keratinocytes: autocrine growth, the effects of exogenous recombinant cytokine, and apparent requirement for heparin-like glycosaminoglycans.
    Piepkorn M; Lo C; Plowman G
    J Cell Physiol; 1994 Apr; 159(1):114-20. PubMed ID: 8138579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The endothelial heparan sulfate-antithrombin III natural anticoagulant pathway in normal and transplanted human kidneys.
    Absher E; Labarrere CA; Carter C; Haag B; Faulk WP
    Transplantation; 1992 Apr; 53(4):828-34. PubMed ID: 1566349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of endothelial cell surface heparin-like polysaccharides.
    Marcum JA; Rosenberg RD
    Ann N Y Acad Sci; 1989; 556():81-94. PubMed ID: 2660690
    [No Abstract]   [Full Text] [Related]  

  • 25. Association of thrombospondin of endothelial cells with other matrix proteins and cell attachment sites and migration tracks.
    Vischer P; Völker W; Schmidt A; Sinclair N
    Eur J Cell Biol; 1988 Oct; 47(1):36-46. PubMed ID: 3229419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of glycosaminoglycans on the growth of cultured tumor cells.
    Nagasawa S
    J Osaka Dent Univ; 1993 Oct; 27(2):121-33. PubMed ID: 8182504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombin III metabolism in the pulmonary vessel endothelium.
    Proietta M; Pulignano I; Del Porto F; Tritapepe L; Di Giovanni C; Caronti B; Guglielmi R; Aliberti G
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):237-40. PubMed ID: 17413759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of heparan sulfate and its fractions with endothelial cells in culture.
    Tiozzo R; Cingi MR; Croce MA
    Int J Tissue React; 1993; 15(4):163-8. PubMed ID: 8188456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain.
    Booth BA; Boes M; Andress DL; Dake BL; Kiefer MC; Maack C; Linhardt RJ; Bar K; Caldwell EE; Weiler J
    Growth Regul; 1995 Mar; 5(1):1-17. PubMed ID: 7538367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Structures and biological activities of heparin-like molecules].
    Itano N; Okayama M
    Seikagaku; 1992 Jul; 64(7):513-20. PubMed ID: 1402210
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies of heparin binding to antithrombin III by crossed immunoelectrophoresis.
    Barrowcliffe TW
    Thromb Haemost; 1980 Feb; 42(5):1434-45. PubMed ID: 7368150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparan sulfates: physiologic regulators of smooth muscle cell proliferation?
    Castellot JJ
    Am J Respir Cell Mol Biol; 1990 Jan; 2(1):11-2. PubMed ID: 2137706
    [No Abstract]   [Full Text] [Related]  

  • 33. Is heparan sulphate the agent of the amphibian inductor?
    Landström U; Lovtrup S
    Acta Embryol Exp (Palermo); 1977 Sep; (2):171-8. PubMed ID: 144395
    [No Abstract]   [Full Text] [Related]  

  • 34. Heparin-like polysaccharides in intra- and extravascular coagulation reactions.
    Lindahl U; Pejler G
    Acta Med Scand Suppl; 1987; 715():139-44. PubMed ID: 2954435
    [No Abstract]   [Full Text] [Related]  

  • 35. Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: evidence for proteolysis of cell-surface molecules.
    Ihrcke NS; Platt JL
    J Cell Physiol; 1996 Sep; 168(3):625-37. PubMed ID: 8816917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzymatic lysis of sulfated glycosaminoglycans reduces the electrophoretic mobility of vascular endothelial cells.
    Vargas FF; Osorio HM; Basilio C; De Jesus M; Ryan US
    Membr Biochem; 1990; 9(2):83-9. PubMed ID: 2103936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of antithrombin III as a regulator of in vivo coagulation.
    Bauer KA; Rosenberg RD
    Semin Hematol; 1991 Jan; 28(1):10-8. PubMed ID: 2017686
    [No Abstract]   [Full Text] [Related]  

  • 38. Thrombogenicity of the injured vessel wall--role of antithrombin and heparin.
    Frebelius S; Hedin U; Swedenborg J
    Thromb Haemost; 1994 Jan; 71(1):147-53. PubMed ID: 8165634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycosaminoglycans mediate cell surface oligomerization of chemokines.
    Hoogewerf AJ; Kuschert GS; Proudfoot AE; Borlat F; Clark-Lewis I; Power CA; Wells TN
    Biochemistry; 1997 Nov; 36(44):13570-8. PubMed ID: 9354625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-inflammatory properties of a heparin-like glycosaminoglycan with reduced anti-coagulant activity isolated from a marine shrimp.
    Brito AS; Arimatéia DS; Souza LR; Lima MA; Santos VO; Medeiros VP; Ferreira PA; Silva RA; Ferreira CV; Justo GZ; Leite EL; Andrade GP; Oliveira FW; Nader HB; Chavante SF
    Bioorg Med Chem; 2008 Nov; 16(21):9588-95. PubMed ID: 18835720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.